Zscaler ($ZS) Insider Trading & Smart Money Activity
Zscaler, Inc. ($ZS) has 13 insider trades, 1 13F position change and 36 analyst ratings on file. In the last 12 months on the open market, no insider bought and 8 insiders sold ($9.45M), net -$9.45M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 8
- Net insider $ (12 mo)
- -$9.45M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 1
- Analyst ratings on file
- 36
ZS insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 8 · $2.49M | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 3 · $1.31M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 2 · $5.65M | 0 / 0 | 0 / 1 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ZS insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 13F | Eagle Strategies | Sold out | -4.18K sh | — | |||||||
| Analyst | Citigroup | Reiterates to Buy | PT $260 | Read | |||||||
| Insider | Geller AdamChief Product Officer | Sell (Open-market sale) 10b5-1 | 1.04K sh | $245.86K | Read | ||||||
| Insider | Geller AdamChief Product Officer | Sell (Open-market sale) 10b5-1 | 23.96K sh | $5.40M | -11.3% | Read | |||||
| Analyst | Citizens | Reiterates to Market Outperform | PT $265 | -11.3% | Read | ||||||
| Analyst | Amerx | Reiterates to Buy | PT $305 | +1.7% | — | ||||||
| Analyst | Wells Fargo | Reiterates to Overweight | PT $260 | +3.4% | — | ||||||
| Analyst | Wedbush | Reiterates to Outperform | PT $240 | +3.4% | — | ||||||
| Analyst | UBS | Reiterates to Buy | PT $250 | +3.4% | — | ||||||
| Analyst | Truist Securities | Reiterates to Buy | PT $250 | +3.4% | — | ||||||
| Analyst | TD Cowen | Reiterates to Buy | PT $230 | +3.4% | — | ||||||
| Analyst | Stifel | Reiterates to Buy | PT $235 | +3.4% | — | ||||||
| Analyst | Stephens | Reiterates to Overweight | PT $265 | +3.4% | — | ||||||
| Analyst | Scotiabank | Reiterates to Sector Outperform | PT $255 | +3.4% | — | ||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $236 | +3.4% | — | ||||||
| Analyst | Needham | Reiterates to Buy | PT $255 | +3.4% | — | ||||||
| Analyst | Macquarie | Reiterates to Outperform | PT $250 | +3.4% | — | ||||||
| Analyst | JP Morgan | Reiterates to Overweight | PT $245 | +3.4% | — | ||||||
| Analyst | Jefferies | Reiterates to Buy | PT $250 | +3.4% | — | ||||||
| Analyst | Guggenheim | Reiterates to Buy | PT $254 | +3.4% | — | ||||||
| Analyst | Citigroup | Reiterates to Buy | PT $245 | +3.4% | — | ||||||
| Analyst | Cantor Fitzgerald | Reiterates to Overweight | PT $275 | +3.4% | — | ||||||
| Analyst | Canaccord Genuity | Reiterates to Buy | PT $250 | +3.4% | — | ||||||
| Analyst | BNP Paribas | Reiterates to Outperform | PT $250 | +3.4% | — | ||||||
| Analyst | Barclays | Reiterates to Overweight | PT $225 | +3.4% | — | ||||||
| Analyst | Baird | Reiterates to Outperform | PT $285 | +3.4% | — | ||||||
| Analyst | Scotiabank | Reiterates to Sector Outperform | PT $240 | +11.9% | — | ||||||
| Analyst | Barclays | Reiterates to Overweight | PT $220 | +7.0% | — | ||||||
| Analyst | Wedbush | Reiterates to Outperform | PT $215 | +1.2% | — | ||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $236 | +1.8% | — | ||||||
| Analyst | Mizuho | Reiterates to Outperform | PT $220 | +1.8% | — | ||||||
| Insider | Kevin RubinChief Financial Officer | Sell (Open-market sale) 10b5-1 | 519 sh | $102.39K | +1.8% | — | |||||
| Insider | Schlossman RobertChief Legal Officer | Sell (Open-market sale) 10b5-1 | 5.39K sh | $1.08M | -3.7% | — | |||||
| Insider | Geller AdamChief Product Officer | Sell (Open-market sale) 10b5-1 | 661 sh | $132.20K | -3.7% | — | |||||
| Analyst | Bernstein | Reiterates to Outperform | PT $298 | +8.7% | — | ||||||
| Analyst | Keybanc | Reiterates to buy | PT $176 | +19.0% | +19.0% | Read | |||||
| Insider | Kevin RubinChief Financial Officer | Sell (Open-market sale) 10b5-1 | 3K sh | $372.68K | +19.0% | +19.0% | — | ||||
| Insider | Adam GellerChief Product Officer | Sell (Open-market sale) 10b5-1 | 2.82K sh | $345.36K | +10.9% | +14.7% | — | ||||
| Insider | James Beer | Sell (Open-market sale) 10b5-1 | 177 sh | $22.21K | +2.3% | +20.5% | Read | ||||
| Insider | Robert SchlossmanChief Legal Officer | Sell (Open-market sale) | 3.15K sh | $397.75K | -0.8% | +15.1% | Read | ||||
| Insider | Kevin RubinChief Financial Officer | Sell (Open-market sale) | 1.69K sh | $213.16K | -0.8% | +15.1% | Read | ||||
| Insider | Michael RichCRO and President of WW Sales | Sell (Open-market sale) | 4.18K sh | $528.98K | -0.8% | +15.1% | Read | ||||
| Insider | Adam GellerChief Product Officer | Sell (Open-market sale) | 1.94K sh | $245.27K | -0.8% | +15.1% | Read | ||||
| Insider | Chaudhry Jagtar SinghCEO & Chairman | Sell (Open-market sale) | 2.88K sh | $363.87K | -0.8% | +15.1% | Read | ||||
| Analyst | Stephens | Reiterates to buy | PT $200 | -4.2% | +9.5% | Read | |||||
| Analyst | Canaccord Genuity | Reiterates to buy | PT $210 | -1.0% | +12.5% | Read | |||||
| Analyst | Wedbush | Reiterates to buy | PT $220 | -0.3% | +11.7% | — | |||||
| Analyst | Rosenblatt | Reiterates to buy | PT $200 | -0.3% | +11.7% | — | |||||
| Analyst | Needham | Reiterates to buy | PT $180 | -0.3% | +11.7% | Read | |||||
| Analyst | Macquarie | Reiterates to buy | PT $172 | -0.3% | +11.7% | — |
1W / 1M / 6M = how ZS moved from the trade or filing date.
Insider trading in ZS: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Geller Adam | Chief Product Officer | 3 | -$5.78M | Oct 12, 2026 | |
| Kevin Rubin | Chief Financial Officer | 3 | -$688.23K | Sep 25, 2026 | |
| Schlossman Robert | Chief Legal Officer | 1 | -$1.08M | Sep 21, 2026 | |
| Adam Geller | Chief Product Officer | 2 | -$590.64K | Jun 22, 2026 | |
| James Beer | 1 | -$22.21K | Jun 17, 2026 | ||
| Robert Schlossman | Chief Legal Officer | 1 | -$397.75K | Jun 16, 2026 | |
| Michael Rich | CRO and President of WW Sales | 1 | -$528.98K | Jun 16, 2026 | |
| Chaudhry Jagtar Singh | CEO & Chairman | 1 | -$363.87K | Jun 16, 2026 |
Institutions moving ZS (13F)
Analyst ratings on ZS
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Citigroup | Reiterates | Buy | $245 → $260 | Read | ||||
| Citizens | Reiterates | Market Outperform | $210 → $265 | -11.3% | Read | |||
| Amerx | Reiterates | Buy | $305 | +1.7% | — | |||
| Wells Fargo | Reiterates | Overweight | $215 → $260 | +3.4% | — | |||
| Wedbush | Reiterates | Outperform | $215 → $240 | +3.4% | — | |||
| UBS | Reiterates | Buy | $225 → $250 | +3.4% | — | |||
| Truist Securities | Reiterates | Buy | $200 → $250 | +3.4% | — | |||
| TD Cowen | Reiterates | Buy | $200 → $230 | +3.4% | — | |||
| Stifel | Reiterates | Buy | $200 → $235 | +3.4% | — | |||
| Stephens | Reiterates | Overweight | $225 → $265 | +3.4% | — |
Frequently asked questions
Are ZS insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 8 insiders made 13 open-market sales worth $9.45M, a net -$9.45M.
What is the latest insider trade in ZS?
Geller Adam, Chief Product Officer filed a sell (open-market sale) of 1.04K sh worth $245.86K on Oct 12, 2026.
Which institutions changed their ZS positions?
Recent 13F filers moving the stock include Eagle Strategies.
Other software - infrastructure stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.